+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global AI in Cancer Diagnostics Market by Component (Hardware, Services, Software), Deployment (Cloud, On-Premise), Cancer Type, End-user - Forecast 2024-2030- Product Image
Global AI in Cancer Diagnostics Market by Component (Hardware, Services, Software), Deployment (Cloud, On-Premise), Cancer Type, End-user - Forecast 2024-2030- Product Image
Sale

Global AI in Cancer Diagnostics Market by Component (Hardware, Services, Software), Deployment (Cloud, On-Premise), Cancer Type, End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716125
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The AI in Cancer Diagnostics Market size was estimated at USD 220.38 million in 2023, USD 266.28 million in 2024, and is expected to grow at a CAGR of 21.52% to reach USD 862.50 million by 2030.

Artificial Intelligence (AI) in cancer diagnostics involves the use of advanced algorithms and software to process, analyze, and interpret medical images and data for the detection, diagnosis, and prediction of cancer. These AI-driven systems are equipped with machine learning and deep learning capabilities, which enable them to learn from vast amounts of oncological data, improving their accuracy and efficiency over time. The increasing prevalence of cancer among the global population and the rising need for personalized medicine boost the adoption of AI in the healthcare sector.

Moreover, proliferating adoption in several cancer screening programs worldwide, along with the exponential shift towards non-invasive cancer diagnosis, drives AI integration in cancer therapy. However, the high cost of AI-integrated cancer therapies and the shortage of trained oncologists impact the expansion of AI in the cancer diagnostics market. Furthermore, technological improvements in cancer diagnostics supported by government investments create lucrative opportunities for market growth.

Regional Insights

In the American region, including the United States & Canada, the demand for AI-based cancer diagnostics is driven by a strong emphasis on early detection and personalized medicine. Prominent institutions and companies are investing heavily in AI research, and regulatory agencies such as the FDA are expediting approvals of AI diagnostic tools. Patent filings in AI from companies and academic institutions reflect the innovation in machine learning algorithms for imaging and genomic data analysis. Customers are generally receptive to AI-driven healthcare services, provided privacy and accuracy concerns are addressed.

A host of EU countries engage in comprehensive AI research and development activities in the healthcare sector through government initiatives. The region shows a strong customer need for AI in cancer diagnostics due to aging populations and increased cancer prevalence. In terms of customer purchasing behavior, Europeans tend to favor products and services that comply with stringent GDPR regulations. In the Middle East, with substantial investments in smart health technologies, there's a growing market for AI cancer diagnostic tools. APAC region has a growing market for AI in cancer diagnostics, with its aging population driving consumer needs. In the APAC region, customers are increasingly tech-savvy and open to AI healthcare solutions, while the government's support of AI research has established a burgeoning market for AI in cancer diagnostics.

Market Trends by Segment

  • Component: High-volume testing centers prefer advanced hardware that can handle large-scale data processing with minimal error
  • Cancer Type: Rising significance of AI-driven diagnostic for brain tumors due to complexity & critical need for precise tumor classification

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Owkin Enters Collaboration Agreement With MSD to Develop AI-Powered Diagnostics for Cancer

Biotechnology firm Owkin has solidified a partnership with MSD, known as Merck & Co. in the United States, to pioneer AI-enhanced digital pathology diagnostics tailored for the European Union market. This groundbreaking collaboration aims to refine pre-screening methods for Microsatellite Instability-High (MSI-H), a genomic biomarker critical for prognosticating and guiding treatment in immunotherapy, specifically in cancers such as endometrial, gastric, small intestine, and biliary where MSI-H detection is currently not standard practice despite its significance.

ConcertAI Announces Agreement with Cancer Center to Accelerate and Transform Precision Oncology Through AI-Enabled Imaging Solutions

ConcertAI has established a pivotal multi-year strategic partnership with Memorial Sloan Kettering Cancer Center (MSK) to focus on driving the advancement and implementation of clinical AI algorithms and enhancing imaging workflow integration within clinical trials, as well as augmenting oncology clinical decisions. MSK heralds these advancements as a catalyst for precise diagnostics and better management of treatment, fueling a transformative shift within the radiology and AI community that promises a leap in cancer diagnosis and patient care.

Roche Collaborates with Ibex and Amazon Web Services to Accelerate Adoption of AI-Enabled Digital Pathology Solutions to Help Improve Cancer Diagnoses

F. Hoffmann-La Roche Ltd. has announced collaborations with Ibex Medical Analytics and Amazon Web Services to enhance cancer diagnostics through the navify digital pathology platform, which integrates cutting-edge AI tools for improved accuracy and efficiency in diagnosing breast and prostate cancer. These innovative collaborations aim to streamline pathology workflows by providing secure access to AI-driven decision support, enabling pathologists to deliver precise and expedited patient care.

Key Company Profiles

The report delves into recent significant developments in the AI in Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Aiosyn B.V., Cancer Center.ai, ContextVision AB, Deep Bio Inc., Google LLC by Alphabet Inc., Ibex Medical Analytics Ltd., International Business Machines Corporation, Kheiron Medical Technologies Limited, Lifebit Biotech Ltd, Lunit Inc., Medial EarlySign, Microsoft Corporation, Mindpeak GmbH, Paige AI, Inc., PathAI, Inc., Proscia Inc., Qritive, Quantib B.V., ScreenPoint Medical BV, Siemens Healthineers AG, Tempus Labs, Inc., Therapixel, Visiopharm A/S, Viz.ai, and Xavor Corporation.

This research report offers invaluable insights into various crucial aspects of the AI in Cancer Diagnostics Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer among the global population
5.1.1.2. Proliferating adoption in several cancer screening programs worldwide
5.1.1.3. Exponential shift towards non-invasive cancer diagnosis
5.1.2. Restraints
5.1.2.1. High cost and shortage of trained oncologists
5.1.3. Opportunities
5.1.3.1. Technological improvements in cancer diagnostics
5.1.3.2. Government investments in using AI in cancer diagnostics and treatments
5.1.4. Challenges
5.1.4.1. Vulnerability to cyberattacks and data breaches
5.2. Market Segmentation Analysis
5.2.1. Component: High-volume testing centers prefer advanced hardware that can handle large-scale data processing with minimal error
5.2.2. Cancer Type: Rising significance of AI-driven diagnostic for brain tumors due to complexity & critical need for precise tumor classification
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. AI in Cancer Diagnostics Market, by Component
6.1. Introduction
6.2. Hardware
6.3. Services
6.4. Software
7. AI in Cancer Diagnostics Market, by Deployment
7.1. Introduction
7.2. Cloud
7.3. On-Premise
8. AI in Cancer Diagnostics Market, by Cancer Type
8.1. Introduction
8.2. Brain Tumor
8.3. Breast Cancer
8.4. Colorectal Cancer
8.5. Lung Cancer
8.6. Prostate Cancer
8.7. Skin Cancer
9. AI in Cancer Diagnostics Market, by End-user
9.1. Introduction
9.2. Cancer Centers
9.3. Hospitals
10. Americas AI in Cancer Diagnostics Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific AI in Cancer Diagnostics Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa AI in Cancer Diagnostics Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Owkin Enters Collaboration Agreement With MSD to Develop AI-Powered Diagnostics for Cancer
13.3.2. ConcertAI Announces Agreement with Cancer Center to Accelerate and Transform Precision Oncology Through AI-Enabled Imaging Solutions
13.3.3. Roche Collaborates with Ibex and Amazon Web Services to Accelerate Adoption of AI-Enabled Digital Pathology Solutions to Help Improve Cancer Diagnoses
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. AI IN CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. AI IN CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AI IN CANCER DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. AI IN CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. AI IN CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AI IN CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CLOUD, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SKIN CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY SKIN CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 68. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 69. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 70. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 71. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. CANADA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 76. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 77. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 78. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 79. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 80. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 81. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. MEXICO AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 112. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 113. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 114. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 115. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 116. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 117. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. CHINA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 120. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 121. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 122. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 123. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. INDIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 136. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 137. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 138. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 139. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 140. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 141. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. JAPAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 184. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 185. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 186. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 187. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 188. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 189. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. THAILAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 209. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 210. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 211. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 212. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 213. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 214. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 215. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. DENMARK AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 218. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 219. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 220. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 221. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 222. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 223. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. EGYPT AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 226. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 227. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 228. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 229. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 230. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 231. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. FINLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 234. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 235. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 236. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 237. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 238. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 239. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. FRANCE AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 242. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 243. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 244. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 245. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 246. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 247. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 248. GERMANY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 258. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 259. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 260. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 261. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 262. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 263. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. ITALY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 282. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 283. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 284. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 285. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 286. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 287. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. NORWAY AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 290. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 291. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 292. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 293. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 294. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 295. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 296. POLAND AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 297. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 298. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 299. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 300. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 301. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 302. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 303. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. QATAR AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 324. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 329. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 330. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 331. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2018-2023 (USD MILLION)
TABLE 332. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY DEPLOYMENT, 2024-2030 (USD MILLION)
TABLE 333. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 334. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 335. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 336. SPAIN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN AI IN CANCER DIAGNOSTICS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
TABLE 339. SWEDEN AI IN CANCER DIAGNOSTIC

Companies Mentioned

  • Aiosyn B.V.
  • Cancer Center.ai
  • ContextVision AB
  • Deep Bio Inc.
  • Google LLC by Alphabet Inc.
  • Ibex Medical Analytics Ltd.
  • International Business Machines Corporation
  • Kheiron Medical Technologies Limited
  • Lifebit Biotech Ltd
  • Lunit Inc.
  • Medial EarlySign
  • Microsoft Corporation
  • Mindpeak GmbH
  • Paige AI, Inc.
  • PathAI, Inc.
  • Proscia Inc.
  • Qritive
  • Quantib B.V.
  • ScreenPoint Medical BV
  • Siemens Healthineers AG
  • Tempus Labs, Inc.
  • Therapixel
  • Visiopharm A/S
  • Viz.ai
  • Xavor Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 266.28 Million
Forecasted Market Value ( USD ) by 2030 $ 862.5 Million
Compound Annual Growth Rate21.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030 - Product Image

Global Breast Cancer Diagnostics Market by Technique (Imaging, Molecular Testing, Tissue Biopsy Tests), Cancer Type (BRCA Breast Cancer, EGFR Mutation Test Breast Cancer, ER & PR Breast Cancer), Component, Diagnostic Type, End-User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Artificial Intelligence In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Artificial Intelligence In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 90 Pages
  • Global
From
Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030 - Product Image

Global Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

AI In Oncology Market Size, Share & Trends Analysis Report By Component Type (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
AI in Cancer Diagnostics Global Market Report 2024 - Product Image

AI in Cancer Diagnostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.